🔗 Share this article

Following a hold-up and a particularly heated meeting, a government vaccine expert group was scheduled to decide on Friday concerning altering the longstanding recommendation that each baby be vaccinated against hepatitis B.

Fiery Exchange and a Deferred Vote

The first day of the conference on Thursday was characterized by fiery discussion over curbing eligibility to the hepatitis B vaccine for babies and a resolution to postpone the decision by a day to provide committee members extra time to review the wording. The group, which counsels the CDC on vaccination protocols, had twice before postponed.

“Is there any specific evidence of harm of giving this immunization before 30 days? Or is this theory?” inquired one panel member.

In answer, another member stated, “There is inadequate data about the enduring danger.”

Current Guidelines and Potential Impact

The vaccine is presently advised for every newborn within 24 hours of delivery to halt contraction of hepatitis B, which can result in significant hepatic injury. It has been administered to over a billion individuals for over thirty years.

The Atlanta conference provided no recent proof of injuries resulting from the vaccine. Experts say any alteration to the current hepatitis B vaccine regimen could have significant and far-reaching repercussions for infant and child health in the United States.

Panel Composition and Latest Shifts

The expert committee can only provide advice to the director of the CDC. The group's roster has seen shifts recently, with the statement that the committee’s most recent chair would leave for an official role and be succeeded by a cardiac doctor who has been critical of other vaccines.

The committee includes multiple immunization doubters who are in agreement with a aim to revamp – and perhaps, in some cases, eliminate – traditional vaccination recommendations.